219 related articles for article (PubMed ID: 19584079)
1. Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells.
Lee JI; Nian H; Cooper AJ; Sinha R; Dai J; Bisson WH; Dashwood RH; Pinto JT
Cancer Prev Res (Phila); 2009 Jul; 2(7):683-93. PubMed ID: 19584079
[TBL] [Abstract][Full Text] [Related]
2. Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells.
Nian H; Bisson WH; Dashwood WM; Pinto JT; Dashwood RH
Carcinogenesis; 2009 Aug; 30(8):1416-23. PubMed ID: 19528666
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive mechanisms of α-keto acid metabolites of naturally occurring organoselenium compounds.
Pinto JT; Lee JI; Sinha R; MacEwan ME; Cooper AJ
Amino Acids; 2011 Jun; 41(1):29-41. PubMed ID: 20383543
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine aminotransferase III and glutamine transaminase L are identical enzymes that have cysteine S-conjugate β-lyase activity and can transaminate L-selenomethionine.
Pinto JT; Krasnikov BF; Alcutt S; Jones ME; Dorai T; Villar MT; Artigues A; Li J; Cooper AJ
J Biol Chem; 2014 Nov; 289(45):30950-61. PubMed ID: 25231977
[TBL] [Abstract][Full Text] [Related]
5. Preparative Biocatalytic Synthesis of α-Ketomethylselenobutyrate-A Putative Agent for Cancer Therapy.
Nikulin MV; Drobot VV; Shurubor YI; Švedas VK; Krasnikov BF
Molecules; 2023 Aug; 28(17):. PubMed ID: 37687007
[TBL] [Abstract][Full Text] [Related]
6. The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants.
Cooper AJ
Neurochem Int; 2004 Jun; 44(8):557-77. PubMed ID: 15016471
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
Frønsdal K; Saatcioglu F
Prostate; 2005 Feb; 62(3):299-306. PubMed ID: 15389787
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells.
Pinto JT; Sinha R; Papp K; Facompre ND; Desai D; El-Bayoumy K
Int J Cancer; 2007 Apr; 120(7):1410-7. PubMed ID: 17205524
[TBL] [Abstract][Full Text] [Related]
9. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
Patra N; De U; Kim TH; Lee YJ; Ahn MY; Kim ND; Yoon JH; Choi WS; Moon HR; Lee BM; Kim HS
Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193
[TBL] [Abstract][Full Text] [Related]
10. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.
Myzak MC; Hardin K; Wang R; Dashwood RH; Ho E
Carcinogenesis; 2006 Apr; 27(4):811-9. PubMed ID: 16280330
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Organoselenium Compounds on Histone Deacetylase Inhibition and Their Potential for Cancer Therapy.
Adimulam T; Arumugam T; Foolchand A; Ghazi T; Chuturgoon AA
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884764
[TBL] [Abstract][Full Text] [Related]
13. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
Trtková K; Pašková L; Matiješčuková N; Kolář Z
Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266
[TBL] [Abstract][Full Text] [Related]
14. A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL.
Hwang JJ; Kim YS; Kim T; Kim MJ; Jeong IG; Lee JH; Choi J; Jang S; Ro S; Kim CS
Invest New Drugs; 2012 Aug; 30(4):1434-42. PubMed ID: 21773733
[TBL] [Abstract][Full Text] [Related]
15. Seleno-aspirin compound AS-10 promotes histone acetylation ahead of suppressing androgen receptor transcription, G1 arrest, and apoptosis of prostate cancer cells.
Karelia DN; Kim S; Plano D; Sharma AK; Jiang C; Lu J
Prostate; 2023 Jan; 83(1):16-29. PubMed ID: 35996318
[TBL] [Abstract][Full Text] [Related]
16. Binding of AR to SMRT/N-CoR complex and its co-operation with PSA promoter in prostate cancer cells treated with natural histone deacetylase inhibitor NaB.
Trtkova K; Paskova L; Matijescukova N; Strnad M; Kolar Z
Neoplasma; 2010; 57(5):406-14. PubMed ID: 20568894
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer.
Kulp SK; Chen CS; Wang DS; Chen CY; Chen CS
Clin Cancer Res; 2006 Sep; 12(17):5199-206. PubMed ID: 16951239
[TBL] [Abstract][Full Text] [Related]
18. 3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells.
Beaver LM; Yu TW; Sokolowski EI; Williams DE; Dashwood RH; Ho E
Toxicol Appl Pharmacol; 2012 Sep; 263(3):345-51. PubMed ID: 22800507
[TBL] [Abstract][Full Text] [Related]
19. A purified cysteine conjugate beta-lyase from rat kidney cytosol. Requirement for an alpha-keto acid or an amino acid oxidase for activity and identity with soluble glutamine transaminase K.
Stevens JL; Robbins JD; Byrd RA
J Biol Chem; 1986 Nov; 261(33):15529-37. PubMed ID: 3782077
[TBL] [Abstract][Full Text] [Related]
20. Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription.
Cho SD; Jiang C; Malewicz B; Dong Y; Young CY; Kang KS; Lee YS; Ip C; Lü J
Mol Cancer Ther; 2004 May; 3(5):605-11. PubMed ID: 15141018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
